Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL. clonoSEQ is the only DLBCL MRD assay available for clinical u ...

Broadband and mobile operator Vodafone UK has today announced that they've successfully conducted trials with Ericsson of ...

The California Cannabis Market 2024 Report attempts to paint a picture of industry stability, citing increased biomass ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according ...

Limula has unveiled LimONE, a cell therapy manufacturing solution that automates complex and fragmented processes into a ...

For nearly 50 years, doctors have known that the drug retinoic acid helps treat neuroblastoma, a type of solid tumor that ...

The Environmental Protection Agency will host a public update next week on the former Creese & Cook Tanner Superfund site in ...

Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.

People in Slovakia are already starting to feel the first effects of the consolidation measures prepared by the government of Robert Fico (Smer). Even a family of three living in a village and trying ...

Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients ...

Fat Transport Deficiency Unveiled as Key Factor in Rare Childhood Metabolic CrisesResearchers studying a protein linked to a ...